These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25589615)

  • 1. Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment.
    Natori A; Ogata T; Sumitani M; Kogure T; Yamauchi T; Yamauchi H
    Clin Cancer Res; 2015 Mar; 21(6):1348-52. PubMed ID: 25589615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct evidence of central nervous system axonal damage in patients with postoperative delirium: A preliminary study of pNF-H as a promising serum biomarker.
    Inoue R; Sumitani M; Ogata T; Chikuda H; Matsubara T; Kato S; Shimojo N; Uchida K; Yamada Y
    Neurosci Lett; 2017 Jul; 653():39-44. PubMed ID: 28504118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
    Mietani K; Sumitani M; Ogata T; Shimojo N; Inoue R; Abe H; Kawamura G; Yamada Y
    PLoS One; 2019; 14(10):e0222721. PubMed ID: 31574089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathy.
    Sumitani M; Ogata T; Natori A; Hozumi J; Shimojo N; Kida K; Yamauchi H; Yamauchi T
    Biomed Rep; 2016 Jun; 4(6):758-760. PubMed ID: 27284419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated neurofilament subunit levels in the serum of cervical compressive myelopathy patients.
    Kato S; Chikuda H; Ohya J; Hayakawa K; Takeshita K; Tanaka S; Ogata T
    J Clin Neurosci; 2015 Oct; 22(10):1638-42. PubMed ID: 26195334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage.
    Cai JY; Lu C; Chen MH; Ba HJ; Chen XD; Lin JH; Sun J
    Clin Chim Acta; 2013 Sep; 424():182-6. PubMed ID: 23810564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
    Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
    J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylated neurofilament H (pNF-H) as a potential diagnostic marker for neurological disorders in horses.
    Intan-Shameha AR; Divers TJ; Morrow JK; Graves A; Olsen E; Johnson AL; Mohammed HO
    Res Vet Sci; 2017 Oct; 114():401-405. PubMed ID: 28750210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study.
    Hayakawa K; Okazaki R; Ishii K; Ueno T; Izawa N; Tanaka Y; Toyooka S; Matsuoka N; Morioka K; Ohori Y; Nakamura K; Akai M; Tobimatsu Y; Hamabe Y; Ogata T
    Spinal Cord; 2012 Jul; 50(7):493-6. PubMed ID: 22270191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
    Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
    Gresle MM; Liu Y; Dagley LF; Haartsen J; Pearson F; Purcell AW; Laverick L; Petzold A; Lucas RM; Van der Walt A; Prime H; Morris DR; Taylor BV; ; Shaw G; Butzkueven H
    J Neurol Neurosurg Psychiatry; 2014 Nov; 85(11):1209-13. PubMed ID: 24639436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury.
    Shaw G; Yang C; Ellis R; Anderson K; Parker Mickle J; Scheff S; Pike B; Anderson DK; Howland DR
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1268-77. PubMed ID: 16176808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Serum Phosphorylated Neurofilament Heavy Subunit as a Predictive Marker for Outcome in Adult Patients after Traumatic Brain Injury.
    Shibahashi K; Doi T; Tanaka S; Hoda H; Chikuda H; Sawada Y; Takasu Y; Chiba K; Nozaki T; Hamabe Y; Ogata T
    J Neurotrauma; 2016 Oct; 33(20):1826-1833. PubMed ID: 27098610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.
    Falleti MG; Sanfilippo A; Maruff P; Weih L; Phillips KA
    Brain Cogn; 2005 Oct; 59(1):60-70. PubMed ID: 15975700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Phosphorylated Neurofilament Heavy Subunit-H, a Potential Predictive Biomarker for Postoperative Cognitive Dysfunction in Elderly Subjects Undergoing Hip Joint Arthroplasty.
    Zhang H; Zheng J; Wang R; Wu G; Chen J
    J Arthroplasty; 2019 Aug; 34(8):1602-1605. PubMed ID: 31029495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy and cognitive dysfunction in breast cancer patients.
    J Support Oncol; 2006 Feb; 4(2):66-7. PubMed ID: 16499119
    [No Abstract]   [Full Text] [Related]  

  • 18. Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinal fluid of patients with acutely worsening symptoms of compression myelopathy.
    Takahashi H; Aoki Y; Nakajima A; Sonobe M; Terajima F; Saito M; Taniguchi S; Yamada M; Watanabe F; Furuya T; Koda M; Yamazaki M; Takahashi K; Nakagawa K
    J Clin Neurosci; 2014 Dec; 21(12):2175-8. PubMed ID: 25065845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury.
    Anderson KJ; Scheff SW; Miller KM; Roberts KN; Gilmer LK; Yang C; Shaw G
    J Neurotrauma; 2008 Sep; 25(9):1079-85. PubMed ID: 18729720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.